Loading clinical trials...
Loading clinical trials...
Asthma Phenotypes in the Inner City (ICAC-19)
This is an epidemiologic, multi-center, cross-sectional study to define the phenotypic characteristics of Difficult-to-Treat asthma, among children between the ages of 6 to 17 years, receiving one year of guidelines-based therapy for asthma and rhinitis/rhinosinusitis.
Asthma is a complex, heritable disease that affects more than 11.2% of the U.S. population, which represents approximately 9 million children and 23 million adults. Although the underlying characteristics of asthma exist in virtually all patients, the clinical expression of the disease and response to treatment are highly variable. The purpose of this study is to identify characteristics that will discriminate Difficult-to-Treat from Easy-to-Treat asthma in a defined inner-city population adherent to study-directed asthma treatment and management.
Age
6 - 17 years
Sex
ALL
Healthy Volunteers
No
National Jewish Health
Denver, Colorado, United States
Children's National Medical Center
Washington D.C., District of Columbia, United States
Children's Memorial Hospital
Chicago, Illinois, United States
Johns Hopkins University
Baltimore, Maryland, United States
Boston University School of Medicine
Boston, Massachusetts, United States
Henry Ford Health Center
Detroit, Michigan, United States
Columbia University Medical Center
New York, New York, United States
Cincinnati Children's Hospital
Cincinnati, Ohio, United States
University of Texas Southwestern Medical School
Dallas, Texas, United States
Start Date
August 1, 2011
Primary Completion Date
September 1, 2014
Completion Date
September 1, 2014
Last Updated
March 16, 2017
717
ACTUAL participants
Guidelines-based asthma and rhinitis/rhinosinusitis therapy
DRUG
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
NCT07486401
NCT07219173
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT02327897